Epilepsy cases in pregnant and postpartum women: A practical approach

Seminars in Neurology

Volumn 31, Issue 4, 2011, Pages 392-396

  Klein, Autumn M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Epilepsy; management; postpartum; pregnancy; women

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; FOLIC ACID; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ARTICLE; BIRTH DEFECT; BREAST FEEDING; CONGENITAL MALFORMATION; FEMALE; HUMAN; MYOCLONUS EPILEPSY; NEURAL TUBE DEFECT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; SIDE EFFECT; SLEEP DEPRIVATION; TERATOGENICITY; UNSPECIFIED SIDE EFFECT;

ADULT; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 82155192845     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1293538     Document Type: Article

References (12)

1. Harden C L., Hopp J, Ting T Y. et al, American Academy of Neurology American Epilepsy Society. Practice parameter update: management issues for women with epilepsyfocus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009 73 2 126-132
2. Harden C L., Meador K J., Pennell P B. et al, American Academy of Neurology American Epilepsy Society. Practice parameter update: management issues for women with epilepsyfocus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009 73 2 133-141
3. Harden C L., Pennell P B., Koppel B S. et al, American Academy of Neurology American Epilepsy Society. Practice parameter update: management issues for women with epilepsyfocus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009 73 2 142-149
4. Hoyert D L., Mathews T J., Menacker F et al. Annual summary of vital statistics: 2004. Pediatrics 2006 117 168-183 (Pubitemid 46050534)
5. Cunnington M C., Weil J G., Messenheimer J A., Ferber S, Yerby M, Tennis P. Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology 2011 76 21 1817-1823
6. Tomson T, Battino D. Teratogenic effects of antiepileptic medications. Neurol Clin 2009 27 4 993-1002
7. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. ACOG educational bulletin. Seizure disorders in pregnancy. Number 231, December 1996. Int J Gynaecol Obstet 1997 56 3 279-286
8. De Wals P, Tairou F, Van Allen M I. et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007 357 2 135-142 (Pubitemid 47057731)
9. Meador K J., Baker G A., Browning N et al, NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009 360 16 1597-1605
10. Pennell P B., Peng L, Newport D J. et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 2008 70 22 Pt 2 2130-2136
11. EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006 66 3 354-360
12. Meador K J., Baker G A., Browning N et al, NEAD Study Group. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology 2010 75 22 1954-1960